SLATE BIO
Slate Bio is an immunotherapeutics development company that develops therapies that restore the body's natural immunological response in different diseases using bifunctional IL233 cytokine, thereby providing users with an independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics.
SLATE BIO
Industry:
Biotechnology Medical Therapeutics
Founded:
2020-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.slatebio.com
Status:
Active
Contact:
703-456-8000
Email Addresses:
[email protected]
Total Funding:
1.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Apache Global Site Tag
Similar Organizations
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Investors List
Virginia Venture Partners
Virginia Venture Partners investment in Seed Round - Slate Bio
UVA Licensing & Ventures Group
UVA Licensing & Ventures Group investment in Seed Round - Slate Bio
VTC Seed Fund
VTC Seed Fund investment in Seed Round - Slate Bio
Epidarex Capital
Epidarex Capital investment in Seed Round - Slate Bio
PharmaDirections
PharmaDirections investment in Seed Round - Slate Bio
Official Site Inspections
http://www.slatebio.com
- Host name: host.mytechtailor.com
- IP address: 208.75.148.200
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Slate Bio"
Slate Bio - Crunchbase Company Profile & Funding
Slate Bio is an immunotherapeutics development company that develops therapeutic solutions for autoimmune diseases. View contacts for Slate Bio to access new leads and connect with …See details»
Slate Bio
For more information, contact [email protected] © 2024 Slate Bio, Inc. All Rights Reserved.See details»
Slate Bio Company Profile 2024: Valuation, Funding
Developer of immunotherapeutics intended for autoimmune and inflammatory diseases designed to induce antigen expression in a gene of autoimmune diseases.See details»
Slate Bio, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Slate Bio, Inc. of Charlottesville, VA. Get the latest business insights from Dun & Bradstreet.See details»
Slate Bio - Overview, News & Similar companies | ZoomInfo.com
Slate Bio contact info: Phone number: (434) 989-6299 Website: www.slatebio.com What does Slate Bio do? Founded in 2020, Slate Bio is a biotechnology company with a focus on …See details»
Slate Bio - Products, Competitors, Financials, Employees, …
Slate Bio operates as a company focused on the healthcare sector, specifically in the domain of advanced therapies for autoimmune diseases. The company's main offerings include the …See details»
Slate Bio - VentureRadar
Website: https://slatebio.com/ Develops innovative therapies to restore natural immunological response in diseases, focusing on bifunctional IL233 cytokine to augment and expand Tregs. …See details»
Slate Bio - LinkedIn
Slate Bio | 20 followers on LinkedIn. Developing bifunctional cytokines for Tissue Targeting Tregs in Autoimmune Diseases | Slate Bio is developing bifunctional cytokines for Tissue...See details»
Slate Bio - CvilleBioHub
Slate Bio Inc. is a privately held pre-clinical stage biotechnology company.See details»
Slate Bio • UVA Licensing & Ventures Group
Slate Bio Inc. is a privately held pre-clinical stage biotechnology company, spun out of the University of Virginia, creating therapies that restore the body's natural immunological …See details»
Slate Bio - Funding, Financials, Valuation & Investors - Crunchbase
Slate Bio is an immunotherapeutics development company that develops therapeutic solutions for autoimmune diseases.See details»
Slate Bio Raises $1.75 Million in Quest to Commercialize U ... - citybiz
Jan 19, 2023 · Slate Bio has closed on $1.75 million, as the Charlottesville, Va.-based startup uses technology developed at the University of Virginia to develop drugs for autoimmune and …See details»
Slate Bio Launches with Seed Financing to Develop Next …
Jan 19, 2021 · Slate is a pre-clinical biotechnology company developing paradigm shifting IL-2 compounds based on research conducted at the University of Virginia School of Medicine. …See details»
Slate Bio Launches with Seed Financing to Develop Next ... - BioBuzz
Slate is a pre-clinical biotechnology company developing paradigm shifting IL-2 compounds based on research conducted at the University of Virginia School of Medicine. IL233, Slate’s lead …See details»
Slate Bio Launches with Seed Financing to Develop Next
Jan 19, 2021 · Slate is a pre-clinical biotechnology company developing paradigm shifting IL-2 compounds based on research conducted at the University of Virginia School of Medicine. …See details»
Virginia's Slate Bio lands seed funding to tackle autoimmune ...
Jan 27, 2021 · Slate Bio Inc., a startup developing an interleukin 2 fusion cytokine for the potential treatment of autoimmune and inflammatory diseases, has closed a $1.75 million seed …See details»
Slate Bio Launches with Seed Financing to Develop Next …
Jan 19, 2021 · CHARLOTTESVILLE, Va. —Slate Bio, Inc., announced today the closing of a $1.75 million venture financing. Epidarex Capital led the investment round with participation …See details»
Slate Bio Launches with Seed Financing to Develop Next …
Jan 20, 2021 · Slate is a pre-clinical biotechnology company developing paradigm shifting IL-2 compounds based on research conducted at the University of Virginia School of Medicine. …See details»
Slate Bio Launches with Seed Financing to Develop Next …
Jan 19, 2021 · Slate is a pre-clinical biotechnology company developing paradigm shifting IL-2 compounds based on research conducted at the University of Virginia School of Medicine. …See details»
Slate Bio Launches with Seed Financing to Develop ... - Markets …
CHARLOTTESVILLE, Va., Jan. 19, 2021 /PRNewswire/ -- Slate Bio, Inc., announced today the closing of a $1.75 million venture financing. Epidarex Ca...See details»